STAHIST AD
- Product NDC
- 58407-625
- 11-digit product format
- 584070625
- Labeler code
- 58407
- Product ID
- 58407-625_4041d3f9-d1cb-0931-e063-6394a90a82de
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Magna Pharmaceuticals, Inc.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-12-20
- Substance
- CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 25; 60 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- STAHIST AD
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORCYCLIZINE HYDROCHLORIDE | 25 mg/1 |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 60 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NPB7A7874U, 6V9V2RYJ8N |
| Rxcui | 1235861, 1236716 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 58407-625-01 | STAHIST AD | 1 in 1 BLISTER PACK | TABLET | 1 | | 8 |
| 58407-625-06 | STAHIST AD | 6 in 1 BOX | TABLET | 6 | | 8 |
| 58407-625-30 | STAHIST AD | 30 in 1 BOTTLE | TABLET | 30 | | 8 |
| 58407-625-30 | STAHIST AD | 1 in 1 BOX | TABLET | 1 | | 8 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CHLORCYCLIZINE HYDROCHLORIDE | ACTIVE INGREDIENT | NPB7A7874U | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| PSEUDOEPHEDRINE HYDROCHLORIDE | ACTIVE INGREDIENT | 6V9V2RYJ8N | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| CHLORCYCLIZINE | ACTIVE MOIETY | M26C4IP44P | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| PSEUDOEPHEDRINE | ACTIVE MOIETY | 7CUC9DDI9F | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 58407-625 | STAHIST AD (CHLORCYCLIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET [MAGNA PHARMACEUTICALS, INC.] | 7 | Current NDC, Legacy NDC, 4 package rows | 20241207_ccedbc38-2479-4c35-9f86-a9f29bcfab3f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58407-625-01 | 58407062501 | 1 TABLET in 1 BLISTER PACK (58407-625-01) | 1 tablet | 2019-09-01 | 0000-00-00 | No | No | Current |
| 58407-625-06 | 58407062506 | 6 BLISTER PACK in 1 BOX (58407-625-06) / 1 TABLET in 1 BLISTER PACK (58407-625-01) | 6 blister pack | 2011-12-20 | 0000-00-00 | No | No | Current |
| 58407-625-30 | 58407062530 | 1 BOTTLE in 1 BOX (58407-625-30) / 30 TABLET in 1 BOTTLE | 1 bottle | 2011-12-20 | 0000-00-00 | No | No | Current |